This Israeli startup leverages AI to help pathologists handle their workload
Avi Veidman was prompted to create the Tel Aviv-based company, Nucleai, after witnessing his father anxiously wait about 30 days to receive his biopsy results.
Avi Veidman was prompted to create the Tel Aviv-based company, Nucleai, after witnessing his father anxiously wait about 30 days to receive his biopsy results.